The goal of this activity is for learners to be better able to identify the latest clinical evidence and insights on drug-induced PAH including the mechanisms, risk factors, diagnosis, and management to provide optimal patient care.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001211
- Start Date: 2024-06-18 05:00:00
- End Date: 2024-06-18 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Janssen (Any division) - Amount: 91396.0 - Is Kind Support: False Source: Merck - Amount: 38589.0 - Is Kind Support: False Source: United Therapeutics - Amount: 20310.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cardiovascular Disease, Internal Medicine, Pulmonary Disease
Subscribe
Login
0 Comments
Oldest